글로벌 뇌 임플란트 시장 (2023-2032) : 뇌심부 자극, 미주 신경 자극 (VNS)

■ 영문 제목 : Brain Implant Market By Type (Deep brain stimulation, Vagus nerve stimulation), By Application (Parkinson's disease, Epilepsy, Others), By End User (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Research가 발행한 조사보고서이며, 코드는 ALD23SEP126 입니다.■ 상품코드 : ALD23SEP126
■ 조사/발행회사 : Allied Market Research
■ 발행일 : 2023년 4월
■ 페이지수 : 250
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 세계
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD5,730 ⇒환산₩7,735,500견적의뢰/주문/질문
5 UserUSD6,450 ⇒환산₩8,707,500견적의뢰/주문/질문
Enterprise UserUSD9,600 ⇒환산₩12,960,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
2022년 14억 달러 규모의 글로벌 뇌 임플란트 시장은 2023년부터 2032년까지 12.2%의 연평균 성장률을 보이며 2032년에는 45억 달러에 달할 것으로 예상됩니다.뇌 임플란트는 뇌 기능을 모니터링하거나 제어하기 위해 뇌에 외과적으로 이식하는 의료 기기입니다. 뇌 임플란트는 신경 임플란트, 신경 보철 또는 뇌-컴퓨터 인터페이스(BCI)라고도 합니다. 뇌 임플란트는 신경학적 장애나 부상을 입은 사람들의 상실된 기능을 회복하거나 삶의 질을 개선하는 데 도움이 되도록 설계되었습니다. 여러 유형의 뇌 임플란트가 있으며, 각 임플란트는 특정 목적을 위해 설계되었습니다. 일부 뇌 임플란트는 파킨슨병이나 뇌전증과 같은 신경 장애를 치료하는 데 사용됩니다. 이러한 임플란트는 뇌의 특정 부위에 전기 충격을 전달하여 증상을 완화하는 방식으로 작동합니다. 또한 기존 약물에 비해 신경의 전기 자극은 표적화되고 조절 가능한 자극, 전신 부작용 위험 감소, 장기적인 이점 가능성 등 여러 가지 이점을 제공할 수 있습니다.

글로벌 뇌 임플란트 시장 성장은 주로 우울증과 같은 생활 습관병 유병률 증가, 신경계 질환의 증가, 신경학 R&D 투자에 의해 주도되고 있습니다. 예를 들어, 세계보건기구(WHO)에 따르면 전 세계 10억 명 이상의 사람들이 어떤 종류의 신경 질환의 영향을 받고 있습니다. 따라서 이러한 질환의 유병률은 신경 질환을 관리하고 치료하기 위한 뇌 임플란트에 대한 수요를 증가시킵니다. 또한 기술적으로 진보 된 제품의 채택과 고령화 인구의 급증은 간질 및 파킨슨 병과 같은 신경 장애에 더 취약하기 때문에 시장의 성장을 촉진합니다.
그러나 뇌 임플란트와 관련된 높은 비용과 일부 국가의 숙련된 인력 부족은 시장 성장을 어느 정도 방해합니다. 또한 체내 이식으로 인한 알레르기 반응과 약물 요법 및 수술과 같은 다른 치료 옵션의 가용성과 같은 부작용은 시장 성장을 제한합니다.

또한 개발 및 기술 발전으로 인해 뇌 임플란트의 효과와 접근성이 향상되어 시장 성장을 주도 할 것으로 예상됩니다. 또한 다양한 상태를 치료하기 위해 뇌 임플란트의 장점에 대한 의료 제공자와 환자 간의 인식이 급증하면서 예측 기간 동안 시장 수요가 증가 할 것으로 예상됩니다.
뇌 임플란트 시장은 유형, 응용 프로그램, 최종 용도 및 지역으로 분류됩니다. 유형별로 시장은 심부 뇌 자극과 미주 신경 자극으로 분류됩니다. 응용 프로그램별로 시장은 파킨슨 병, 간질 및 기타로 분류됩니다. 최종 용도별로 시장은 병원, 신경과 클리닉 및 기타로 나뉩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽 지역), 아시아 태평양(일본, 중국, 인도, 호주, 한국 및 기타 아시아 태평양), 중남미/중동/아프리카(브라질, 남아프리카공화국, 사우디아라비아 및 기타 중남미/중동/아프리카)에서 시장이 분석됩니다.

글로벌 뇌 임플란트 시장에서 활동하는 주요 주요 업체는 Abbott Laboratories, Aleva Neurotherapeutics SA, Boston scientific corporation, Functional Neuromodulation Ltd., Medtronic plc, NeuroPace Inc., Beijing PINS Medical Co., Ltd, LivaNova PLC., MicroTransponder Inc. and SceneRay Co., Ltd. 등이 있습니다. 시장에서 활동하는 주요 업체들은 제품 포트폴리오를 확장하기 위한 주요 전략으로 제품 승인 및 제품 출시를 채택했습니다.

이해 관계자를 위한 주요 이점
이 보고서는 2022년부터 2032년까지 뇌 임플란트 시장 분석의 시장 부문, 현재 동향, 추정치 및 역학에 대한 정량적 분석을 제공하여 일반적인 뇌 임플란트 시장 기회를 식별합니다.
시장 조사는 주요 동인, 제약 및 기회와 관련된 정보와 함께 제공됩니다.
포터의 다섯 가지 경쟁 요인 분석은 이해 관계자가 이익 지향적인 비즈니스 결정을 내리고 공급자-구매자 네트워크를 강화할 수 있도록 구매자와 공급 업체의 잠재력을 강조합니다.
뇌 임플란트 시장 세분화에 대한 심층 분석은 지배적인 시장 기회를 결정하는 데 도움이 됩니다.
각 지역의 주요 국가는 글로벌 시장에 대한 매출 기여도에 따라 매핑됩니다.
시장 플레이어 포지셔닝은 벤치마킹을 용이하게하고 시장 플레이어의 현재 위치에 대한 명확한 이해를 제공합니다.
이 보고서에는 지역 및 글로벌 뇌 임플란트 시장 동향, 주요 업체, 시장 세그먼트, 응용 분야 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

주요 시장 부문
유형별
심부 뇌 자극
미주 신경 자극

용도별
파킨슨 병
간질
기타

최종 용도별
병원
신경과 클리닉
기타

지역별
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타 유럽 지역
아시아 태평양
일본
중국
인도
호주
한국
기타 아시아 태평양 지역
중남미/중동/아프리카
브라질
사우디 아라비아
남아프리카 공화국
기타 중동 및 아프리카 지역

주요 기업
○ Abbott Laboratories
○ Aleva Neurotherapeutics SA
○ Beijing PINS Medical Co., Ltd
○ Boston Scientific Corporation
○ Functional Neuromodulation, Ltd.
○ LivaNova PLC
○ Medtronic plc
○ MicroTransponder Inc.
○ NeuroPace, Inc.
○ SceneRay Co., Ltd.
■ 보고서 개요

CHAPTER 1 : 소개
CHAPTER 2 : 개요
CHAPTER 3 : 시장 동향
CHAPTER 4 : 뇌 임플란트 시장, 유형별
CHAPTER 5 : 뇌 임플란트 시장, 용도별
CHAPTER 6 : 뇌 임플란트 시장, 최종 용도별
CHAPTER 7 : 뇌 임플란트 시장, 지역별
CHAPTER 8 : 경쟁 현황
CHAPTER 9 : 기업 정보

■ 보고서 목차

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence neurological disorder
3.4.1.2. Initiatives by government and non-government organizations
3.4.1.3. Rise in geriatric population

3.4.2. Restraints
3.4.2.1. High cost of brain implants

3.4.3. Opportunities
3.4.3.1. Rise in technological advancements

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BRAIN IMPLANT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Deep brain stimulation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Vagus nerve stimulation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: BRAIN IMPLANT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Parkinson’s disease
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Epilepsy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: BRAIN IMPLANT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurology clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BRAIN IMPLANT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Medtronic plc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. LivaNova PLC
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Aleva Neurotherapeutics SA
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Key strategic moves and developments
9.5. NeuroPace, Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Functional Neuromodulation, Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Beijing PINS Medical Co., Ltd
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Abbott Laboratories
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. SceneRay Co., Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. MicroTransponder Inc.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. BRAIN IMPLANT MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2022-2032 ($MILLION)
TABLE 03. BRAIN IMPLANT MARKET FOR VAGUS NERVE STIMULATION, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 05. BRAIN IMPLANT MARKET FOR PARKINSON'S DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. BRAIN IMPLANT MARKET FOR EPILEPSY, BY REGION, 2022-2032 ($MILLION)
TABLE 07. BRAIN IMPLANT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. BRAIN IMPLANT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. BRAIN IMPLANT MARKET FOR NEUROLOGY CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. BRAIN IMPLANT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. BRAIN IMPLANT MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. U.S. BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. U.S. BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. CANADA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. CANADA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. MEXICO BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. MEXICO BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. EUROPE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. EUROPE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. GERMANY BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. GERMANY BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. FRANCE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. FRANCE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. UK BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. UK BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. ITALY BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. ITALY BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. SPAIN BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. SPAIN BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. JAPAN BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. JAPAN BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. CHINA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. CHINA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. INDIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. INDIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. INDIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. LAMEA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. LAMEA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. BRAZIL BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. BRAZIL BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. BRAZIL BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. SAUDI ARABIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SOUTH AFRICA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. REST OF LAMEA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 87. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 89. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 90. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 91. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 92. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 93. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 94. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 95. MEDTRONIC PLC: KEY STRATERGIES
TABLE 96. LIVANOVA PLC: KEY EXECUTIVES
TABLE 97. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 98. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 99. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 100. LIVANOVA PLC: KEY STRATERGIES
TABLE 101. ALEVA NEUROTHERAPEUTICS SA: KEY EXECUTIVES
TABLE 102. ALEVA NEUROTHERAPEUTICS SA: COMPANY SNAPSHOT
TABLE 103. ALEVA NEUROTHERAPEUTICS SA: PRODUCT SEGMENTS
TABLE 104. ALEVA NEUROTHERAPEUTICS SA: PRODUCT PORTFOLIO
TABLE 105. ALEVA NEUROTHERAPEUTICS SA: KEY STRATERGIES
TABLE 106. NEUROPACE, INC.: KEY EXECUTIVES
TABLE 107. NEUROPACE, INC.: COMPANY SNAPSHOT
TABLE 108. NEUROPACE, INC.: PRODUCT SEGMENTS
TABLE 109. NEUROPACE, INC.: PRODUCT PORTFOLIO
TABLE 110. FUNCTIONAL NEUROMODULATION, LTD.: KEY EXECUTIVES
TABLE 111. FUNCTIONAL NEUROMODULATION, LTD.: COMPANY SNAPSHOT
TABLE 112. FUNCTIONAL NEUROMODULATION, LTD.: PRODUCT SEGMENTS
TABLE 113. FUNCTIONAL NEUROMODULATION, LTD.: PRODUCT PORTFOLIO
TABLE 114. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 115. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 116. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 117. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 118. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 119. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 120. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 121. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 122. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 123. SCENERAY CO., LTD.: KEY EXECUTIVES
TABLE 124. SCENERAY CO., LTD.: COMPANY SNAPSHOT
TABLE 125. SCENERAY CO., LTD.: PRODUCT SEGMENTS
TABLE 126. SCENERAY CO., LTD.: PRODUCT PORTFOLIO
TABLE 127. MICROTRANSPONDER INC.: KEY EXECUTIVES
TABLE 128. MICROTRANSPONDER INC.: COMPANY SNAPSHOT
TABLE 129. MICROTRANSPONDER INC.: PRODUCT SEGMENTS
TABLE 130. MICROTRANSPONDER INC.: PRODUCT PORTFOLIO
※본 조사보고서 [글로벌 뇌 임플란트 시장 (2023-2032) : 뇌심부 자극, 미주 신경 자극 (VNS)] (코드 : ALD23SEP126) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 뇌 임플란트 시장 (2023-2032) : 뇌심부 자극, 미주 신경 자극 (VNS)] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!